Extension Study of Long-term Safety and Efficacy of Myozyme for a Single Patient With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored ERT Studies.

Clinical trial NCT00765414 · COMPLETED

Trial details

NCT number: NCT00765414
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pompe Disease Late-Onset Glycogen Storage Disease Type II GSD II

Start date: 2003-04-01
Primary completion: 2006-04-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.